Valuebiotech Winner of EIC Accelerator 2022: A Success for Italian Innovation

Valuebiotech stands out at the European level thanks to its technological innovation, emerging as one of the winners of the EIC Accelerator 2022, one of the most prestigious funding programs for highly innovative startups and SMEs.

With a success rate of less than 5%, the call attracted over 1,000 project submissions from across Europe, selecting only the most promising companies in terms of innovation, scalability, and industrial impact. Among them, Valuebiotech is one of the few Italian companies to receive this recognition, confirming the excellence of its technological vision.

This important achievement will enable the company to accelerate the development of its project—an innovation in the field of robotic surgery—supported by the European Union through funding and access to high-level networks.

Succeeding in such a competitive program is not only a recognition for Valuebiotech but also a positive signal for the Italian innovation ecosystem, demonstrating that groundbreaking ideas can compete and thrive on an international scale.